HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Takehiro Fukami Selected Research

neuropeptide Y5 receptor

10/2006Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.
5/2006A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice.
5/2003Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Takehiro Fukami Research Topics

Disease

8Body Weight (Weight, Body)
09/2009 - 06/2002
5Obesity
08/2009 - 06/2002
2Hyperphagia
05/2003 - 06/2002
1Leukemia
04/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2013
1Overweight
10/2006
1Weight Loss (Weight Reduction)
10/2006
1Hypercholesterolemia
05/2003
1Hyperinsulinism (Hyperinsulinemia)
05/2003
1Dehydration (Water Stress)
11/2002

Drug/Important Bio-Agent (IBA)

5Neuropeptide YIBA
08/2009 - 06/2002
3neuropeptide Y5 receptorIBA
10/2006 - 05/2003
1neuropeptide Y-Y1 receptorIBA
08/2009
1sibutramine (Meridia)FDA Link
07/2008
1Spironolactone (Aldactone)FDA LinkGeneric
07/2008
1NeuropeptidesIBA
10/2006
1trans- N- (1- (2- fluorophenyl)- 3- pyrazolyl)- 3- oxospiro(6- azaisobenzofuran- 1(3H),1'- cyclohexane)- 4'- carboxamideIBA
10/2006
1Leptin ReceptorsIBA
05/2006
1Silica GelIBA
11/2002
1allyl alcohol (allylic alcohol)IBA
11/2002
1ZincIBA
11/2002
1CorticosteroneIBA
06/2002

Therapy/Procedure

5Oral Administration
09/2009 - 06/2002
1Drug Therapy (Chemotherapy)
04/2013
1Intraventricular Infusions
05/2003